VEGFA and breast cancer: The rationale behind using toceranib phosphate in our study was based on that phenotype and some of the therapeutic approaches for aggressive mammary cancer in human medicine focusing on inhibiting VEGF and angiogenesis, which are essential in carcinogenesis [27].